Targeted anti-cancer therapy: Co-delivery of VEGF siRNA and Phenethyl isothiocyanate (PEITC) via cRGD-modified lipid nanoparticles for enhanced anti-angiogenic efficacy

• Main Authors: Bao Li (Author), Haoran Niu (Author), Xiaoyun Zhao (Author), Xiaoyu Huang (Author), Yu Ding (Author), Ke Dang (Author), Tianzhi Yang (Author), Yongfeng Chen (Author), Jizhuang Ma (Author), Xiaohong Liu (Author), Keda Zhang (Author), Huichao Xie (Author), Pingtian Ding (Author)
• Format: Book
• Published: Elsevier, 2024-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Anti-tumor angiogenesis therapy, targeting the suppression of blood vessel growth in tumors, presents a potent approach in the battle against cancer. Traditional therapies have primarily concentrated on single-target techniques, with a specific emphasis on targeting the vascular endothelial growth f...